Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Analytical performances of Optilite® turbidimeter (The Binding Site): a new dedicated analyser for specific proteins determination.

Ghillani P, Dufat L, Sterlin D, Musset L.

Ann Biol Clin (Paris). 2017 Feb 1;75(1):29-37. doi: 10.1684/abc.2016.1203.

PMID:
28073707
2.

Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Schoindre Y, Jallouli M, Tanguy ML, Ghillani P, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Hulot JS, Lechat P, Musset L, Piette JC, Amoura Z, Souberbielle JC, Costedoat-Chalumeau N; Group PLUS.

Lupus Sci Med. 2014 Jun 7;1(1):e000027. doi: 10.1136/lupus-2014-000027. eCollection 2014.

3.

Routine use of Zenit RA, a novel chemiluminescent immunoanalyzer in autoimmune disease diagnosis.

Ghillani P, Dufat L, Himeur S, Miyara M, Amoura Z, Musset L.

Auto Immun Highlights. 2012 Mar 21;3(1):27-31. doi: 10.1007/s13317-012-0032-5. eCollection 2012 Apr.

4.

Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.

Ghillani P, André C, Toly C, Rouquette AM, Bengoufa D, Nicaise P, Goulvestre C, Gleizes A, Dragon-Durey MA, Alyanakian MA, Chretien P, Chollet-Martin S, Musset L, Weill B, Johanet C.

Autoimmun Rev. 2011 Jul;10(9):509-13. doi: 10.1016/j.autrev.2011.03.004. Epub 2011 Apr 5.

PMID:
21447407
5.

Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disorders.

Terrier B, Izzedine H, Musset L, Ghillani P, Deray G, Saadoun D, Cacoub P.

Nephrol Dial Transplant. 2011 Nov;26(11):3577-81. doi: 10.1093/ndt/gfr079. Epub 2011 Mar 7.

PMID:
21382997
6.

Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.

Terrier B, Saadoun D, Sène D, Sellam J, Pérard L, Coppéré B, Karras A, Blanc F, Buchler M, Plaisier E, Ghillani P, Rosenzwajg M, Cacoub P.

Arthritis Rheum. 2009 Aug;60(8):2531-40. doi: 10.1002/art.24703.

7.

Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides.

Terrier B, Saadoun D, Sène D, Ghillani P, Amoura Z, Deray G, Fautrel B, Piette JC, Cacoub P.

Ann Rheum Dis. 2009 Oct;68(10):1564-71. doi: 10.1136/ard.2008.094714. Epub 2008 Oct 28.

PMID:
18957481
8.

Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.

Ghillani P, Rouquette AM, Desgruelles C, Hauguel N, Le Pendeven C, Piette JC, Musset L.

Ann N Y Acad Sci. 2007 Aug;1109:407-13.

PMID:
17785329
9.

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.

Costedoat-Chalumeau N, Amoura Z, Hulot JS, Hammoud HA, Aymard G, Cacoub P, Francès C, Wechsler B, Huong du LT, Ghillani P, Musset L, Lechat P, Piette JC.

Arthritis Rheum. 2006 Oct;54(10):3284-90.

10.

Genetic heterogeneity of the hypervariable region I of Hepatitis C virus and lymphoproliferative disorders.

Rigolet A, Cacoub P, Schnuriger A, Vallat L, Cahour A, Ghillani P, Davi F, Benhamou Y, Piette JC, Thibault V.

Leukemia. 2005 Jun;19(6):1070-6.

PMID:
15843828
11.

Corrected QT interval in anti-SSA-positive adults with connective tissue disease: comment on the article by Lazzerini et al.

Costedoat-Chalumeau N, Amoura Z, Hulot JS, Ghillani P, Lechat P, Funck-Brentano C, Piette JC.

Arthritis Rheum. 2005 Feb;52(2):676-7; author reply 677-8. No abstract available.

12.

Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection.

Vallat L, Benhamou Y, Gutierrez M, Ghillani P, Hercher C, Thibault V, Charlotte F, Piette JC, Poynard T, Merle-Béral H, Davi F, Cacoub P.

Arthritis Rheum. 2004 Nov;50(11):3668-78.

13.

Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.

Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, Musset L, Wechsler B, Duhaut P, Piette JC.

Arthritis Rheum. 2004 Oct;50(10):3187-94.

14.

Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18).

Sasso EH, Martinez M, Yarfitz SL, Ghillani P, Musset L, Piette JC, Cacoub P.

J Immunol. 2004 Sep 1;173(5):3549-56.

15.

Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.

Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.

Arthritis Rheum. 2003 Dec;48(12):3487-96.

16.

Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block.

Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P, Papo T, Fain O, Musset L, Piette JC.

Ann Rheum Dis. 2003 Oct;62(10):1010-2.

17.

Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.

Cacoub P, Rosenthal E, Gerolami V, Hausfater P, Ghillani P, Sterkers Y, Thibault V, Khiri H, Piette JC, Halfon P.

Clin Microbiol Infect. 2003 Jan;9(1):39-44.

18.

Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC.

Arthritis Rheum. 2002 Dec;46(12):3317-26.

19.

Fatigue in patients with chronic hepatitis C.

Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, Ghillani P, Charlotte F, Piette JC, Moussalli J; Multivirc group.

J Viral Hepat. 2002 Jul;9(4):295-303.

PMID:
12081607
20.

Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C.

Cacoub P, Ratziu V, Myers RP, Ghillani P, Piette JC, Moussalli J, Poynard T; Multivirc Group.

J Hepatol. 2002 Jun;36(6):812-8. Erratum in: J Hepatol. 2002 Oct;37(4):545..

PMID:
12044533
21.

Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia.

Kaplanski G, Marin V, Maisonobe T, Sbai A, Farnarier C, Ghillani P, Thirion X, Durand JM, Harlé JR, Bongrand P, Piette JC, Cacoub P.

Clin Exp Immunol. 2002 Jan;127(1):123-30.

22.

Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.

Cacoub P, Renou C, Kerr G, Hüe S, Rosenthal E, Cohen P, Kaplanski G, Charlotte F, Thibault V, Ghillani P, Piette JC, Caillat-Zucman S.

Arthritis Rheum. 2001 Sep;44(9):2118-24.

23.

Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.

Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, Ghillani P, Leblond V, Piette JC.

Am J Hematol. 2001 Jul;67(3):168-71.

24.

Effect of 51p1-related gene copy number (V1-69 locus) on production of hepatitis C-associated cryoglobulins.

Sasso EH, Ghillani P, Musset L, Piette JC, Cacoub P.

Clin Exp Immunol. 2001 Jan;123(1):88-93.

25.

Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.

Cacoub P, Ghillani P, Revelen R, Thibault V, Calvez V, Charlotte F, Musset L, Youinou P, Piette JC.

J Hepatol. 1999 Oct;31(4):598-603.

PMID:
10551381
26.

Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P.

Arthritis Rheum. 1999 Oct;42(10):2204-12.

27.

Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.

Cacoub P, Boukli N, Hausfater P, Garbarg-Chenon A, Ghillani P, Thibault V, Musset L, Huraux JM, Piette JC.

Ann Rheum Dis. 1998 Jul;57(7):422-4.

28.

No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.

Cacoub P, Musset L, Hausfater P, Ghillani P, Fabiani FL, Charlotte F, Angevin E, Opolon P, Poynard T, Piette JC, Autran B.

Clin Exp Immunol. 1998 Jul;113(1):48-54.

29.

Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy.

Musset L, Ghillani P, Lunel F, Cacoub P, Cresta P, Frangeul L, Rosenheim M, Preud'homme JL.

Immunol Lett. 1997 Jan;55(1):41-5.

PMID:
9093880
30.

Distribution of VRA09, an ovarian tumor-associated antigen, distinguishing borderline serous tumors.

Voeltzel T, Duvillard P, Ghillani P, Bénard J, Bohuon C, Bellet D, Bidart JM.

Int J Cancer. 1994 Oct 15;59(2):159-64.

PMID:
7927912
31.

Detection of a 45-kilodalton antigen overexpressed in a cisplatin-resistant human ovarian carcinoma cell line.

Voeltzel T, Lavaissiere L, Ghillani P, Benard J, Bohuon C, Bidart JM.

Hybridoma. 1994 Oct;13(5):367-72.

PMID:
7860093
32.

Specific immunostaining for CCP II, a novel calcitonin carboxyl terminal peptide encoded by the calcitonin/CGRP gene.

Giscard-Dartevelle S, Ghillani P, Taboulet J, Troalen F, Segond N, Lasmoles F.

J Histochem Cytochem. 1993 Nov;41(11):1605-10.

PMID:
7691931
33.

Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases.

Schlumberger M, Gicquel C, Lumbroso J, Tenenbaum F, Comoy E, Bosq J, Fonseca E, Ghillani PP, Aubert B, Travagli JP, et al.

J Endocrinol Invest. 1992 Oct;15(9):631-42.

PMID:
1479146
34.

Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.

Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhommé C, Rougier P, et al.

Cancer Res. 1992 Jul 15;52(14):3901-7.

35.

Immunochemical mapping of antigenic regions on the human thyrotropin beta-subunit by antipeptide antibodies.

Bidart JM, Troalen F, Ghillani P, Puisieux A, Bohuon C, Bellet D.

J Biol Chem. 1991 Oct 15;266(29):19238-44.

36.

Peptide immunogen mimicry of a protein-specific structural epitope on human choriogonadotropin.

Bidart JM, Troalen F, Ghillani P, Rouas N, Razafindratsita A, Bohuon C, Bellet D.

Science. 1990 May 11;248(4956):736-9. Erratum in: Science 1991 Feb 22;251(4996):856.

PMID:
1692160
37.

Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.

Ghillani PP, Motté P, Troalen F, Jullienne A, Gardet P, Le Chevalier T, Rougier P, Schlumberger M, Bohuon C, Bellet D.

Cancer Res. 1989 Dec 1;49(23):6845-51.

38.

Phase I clinical trial of monoclonal anti-human chorionic gonadotropin antibody in women with an ectopic pregnancy.

Frydman R, Fernandez H, Troalen F, Ghillani P, Rainhorn JD, Bellet D.

Fertil Steril. 1989 Nov;52(5):734-8.

PMID:
2806614
39.
40.

Antigenic determinants on human choriogonadotropin alpha-subunit. II. Immunochemical mapping by a monoclonal antipeptide antibody.

Troalen F, Bellet DH, Ghillani P, Puisieux A, Bohuon CJ, Bidart JM.

J Biol Chem. 1988 Jul 25;263(21):10370-6.

41.

Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies.

Motté P, Vauzelle P, Gardet P, Ghillani P, Caillou B, Parmentier C, Bohuon C, Bellet D.

Clin Chim Acta. 1988 May 13;174(1):35-54.

PMID:
2454766
42.

Synthetic peptides and monoclonal antibodies of predetermined specificity in the study of human chorionic gonadotropin.

Bellet DH, Bidart JM, Ozturk M, Troalen F, Ghillani P, Pernas P, Wands JR, Bohuon CJ.

Int J Rad Appl Instrum B. 1987;14(4):295-304. No abstract available.

PMID:
2443467

Supplemental Content

Loading ...
Support Center